cell damage by generation of free radicals or cytotoxic (group CI / IGF) or saline (group CI) on weeks 13 and substances. 10, 11, 15 Lipid peroxidation products may stim-14 (protocol 1) or on weeks 28-30 (protocol 2). Norulate the expression of collagen genes 16 and the activity mal rats were studied in parallel. Results: Serum albuof hepatic prolyl 4-hydroxylase 17 ; these effects seem to be min and total protein levels were reduced in CI but not relevant in the development of fibrosis. [16] [17] [18] [19] Antioxidant in CI / IGF rats compared with normal rats. Clotting enzymes such as superoxide dismutase (SOD), glutathifactors II, VII, and X were significantly greater in CI / IGF than in CI rats. Liver lipid peroxidation products one peroxidase (GSHPx), and catalase [20] [21] [22] play an imwere significantly increased in CI but not in CI / IGF portant role in cell defense against oxidative stress. and activity of antioxidant enzymes in liver tissue.
were reduced compared with normal animals in CI but not in CI / IGF rats. Conclusions: IGF-I improves liver
Materials and Methods
function and reduces oxidative liver damage and fibroInduction of Liver Cirrhosis sis in rats with compensated or advanced liver cirrhoAll experimental procedures were performed in conforsis. Improved mitochondrial function could play a role mity with The Guiding Principles for Research Involving Animals. 24 in the hepatoprotective effect of this hormone. Male Wistar rats (3 weeks old, 130-150 g) were subjected to two different study protocols. Study Design calculated at 1501 magnification scoring 6 points when the mean value of the thickness of 9 septa (3 periportal, 3 periveProtocol 1. The study period (period of administration nous, and 3 perinodular), measured in four different fields, of saline or IGF-1) was initiated 10 days after stopping CCl 4 oscillates around 90-125 mm; score 4, 70-50 mm; and score administration (day 0). Rats were randomly assigned to receive 2, Ç40-30 mm. The number of septa was scored as 4 points either saline (group CI, n Å 10) or recombinant human IGFwhen there were numerous septa extending into the nodules, I (rhIGF-I; 2 mg IGF-Ir100 g body wt 01 rday 01 in two divided thus dissecting a small number of hepatocytes forming microdoses) (group CI / IGF, n Å 10) subcutaneously for 14 days.
nodules; 2-3 points when septa penetrating into nodules were Animals were killed by decapitation 24 hours after receiving less numerous surrounding bigger nodules; and 1 point when the last dose (day 15). Biochemical parameters were deterthere was no formation of micronodules inside macronodules. mined on days 0 and 15 and prothrombin time and clotting Four fields from each preparation were evaluated twice by two factors on day 15. Blood samples were taken from retroocular different observers, receiving a maximum of 14 points each venous plexus with capillary tubes (70 mm; Marienfeld, Gertime. The arithmetical mean of the two scores was taken as many), divided into aliquots, and stored at 020ЊC until used.
the final score. Livers were weighted, and a tissue sample from the left major Liver collagen content was measured by a dye-binding proliver lobe was processed (fixed in Bouin's solution) for histologcedure as described by Jimenez et al. 28 rday 01 in two divided doses; group CI / IGF, n Å 10) or vehicle (group CI, n Å 10) Malondialdehyde (MDA) was used as an index of lipid during the last 21 days of exposure to CCl 4 (weeks 28, 29, peroxidation and was measured after heating samples at 45ЊC and 30). On day 22, animals were killed and liver and blood for 60 minutes in acid medium. It was quantitated by a colorisamples were collected. In this protocol, all animals receiving metric assay using LPO-586 (Bioxytech; OXIS International CCl 4 showed advanced liver cirrhosis with ascites at the end of Inc., Portland, OR), which, after reacting with MDA, generthe study. Serum biochemistry (with the exception of clotting ates a stable chromophore that can be measured at 586 nm factors) was performed as in protocol 1.
(Hitachi U2000 Spectro; Boehringer Mannheim). Determinations were performed in homogenates of liver tissue in Tris-
Analytical Methods
HCl solution (1 g of liver tissue/10 mL) centrifuged at Liver function tests were determined by routine labora3000g during 10 minutes at 4ЊC. tory methods using a Hitachi 747 autoanalyzer (Boehringer Activities of the antioxidant enzymes SOD (E.C. 1.15.1.1), Mannheim, Mannheim, Germany). Prothrombin time was catalase (E.C. 1.11.1.6) and GSHPx (E.C. 1.11.1.9) were meameasured using standard thromboplastin (OrthoRecombiplassured in liver tissue. Liver samples were homogenized in Tristin; Ortho Diagnostics, Raritan, NJ) with a Koagulab 16S
HCl buffer (20 mmol/L, pH 7.4; 1 g tissue/10 mL) at 0ЊC (Ortho Diagnostics). Fibrinogen was assessed according to Von and centrifuged at 25,000g for 30 minutes at 4ЊC. All measureClauss's method. 27 Activity levels of clotting factors II, VII, ments were performed in the supernatant. SOD activity was and X were measured using factor-deficient plasma (Organon determined at 37ЊC using a commercial kit (Ransod; Randox Tecnika Corp., Durham, NC). All values were referred to a Laboratories Ltd., Crumlin, England) and an autoanalyzer (Costandard curve obtained with different dilutions of normal bas Mira; Roche Diagnostic System, Basel, Switzerland). Cataplasma, where 1:10 dilution represented 100% activity for lase activity was determined at 25ЊC by measuring the changes each factor. of absorbance using final concentrations of 10 mmol/L H 2 O 2 and 50 mmol/L phosphate buffer (pH 7.0) at 240 nm during
Histological Degree of Fibrosis and Liver
the time interval 15-30 seconds after addition of the sample. 22 
Collagen Content
The activity was calculated as velocity constant k. Parameters CO (n Å 10) CI (n Å 10) CI / IGF (n Å 10) CO (n Å 10) CI (n Å 10) CI / IGF (n Å 10)
AST (IU/ (Table 1) . Also, on day 21, CI / IGF animals had serum bilirubin values vs. 575 { 96 IU/L), bilirubin (1.1 { 0.4 vs. 1.1 { 0.3 mg/dL), blood glucose (133 { 11 vs. 132 { 12 mg/dL), that were significantly lower than in untreated cirrhotic rats and similar to those of controls (Table 1) . Serum albumin (2.4 { 0.2 vs. 2.3 { 0.2 g/dL), and total proteins (5.71 { 0.9 vs. 5.68 { 0.9 g/dL), and all these transaminase and alkaline phosphatase levels, however, remained significantly elevated compared with CO not values were significantly different from those found in healthy controls (35 { 2, 21 { 1, 240 { 17, 0.3 { only in CI animals but also (although to a lesser extent) in the CI / IGF group (Table 1) . It should be considered 0.1, 161 { 9, 3.34 { 0.03, and 6.7 { 0.1, respectively, for the above-mentioned parameters). In agreement with that in protocol 2 rats were treated with IGF-I during the last 3 weeks of the study without interrupting the findings in protocol 1, at the end of the study, CI rats had blood glucose, albumin, and total protein values that exposure to the toxin. Figure 1 . Clotting factors II, VII, and X, fibrinogen level, and prothrombin time in the three groups of animals studied (protocol 1): healthy rats (CO), untreated cirrhotic rats (CI), and cirrhotic rats treated with IGF-I (CI / IGF). *P õ 0.05.
Liver Histology and Liver Collagen Content animals (28.5 { 1.6) compared with untreated healthy controls (39.0 { 2.4; P õ 0.05). In protocol 1, the histological score of fibrosis was Because the protective effects of IGF-I against oxidasignificanly lower in CI / IGF than in CI rats (7.26 { tive damage are apparent both in protocol 1 (CCl 4 discon-0.60 vs. 9.88 { 0.47; P õ 0.01) (Figure 2 ). In accordance tinued 10 days before initiation of treatment) and in with histological findings, the biochemical quantitation protocol 2 (treatment with IGF-I during the last 3 weeks of liver collagen content (micrograms of collagen per of CCl 4 administration), it seems that IGF-I does not act milligram of protein) was also lower in IGF-I-treated by modifying CCl 4 metabolism but rather by modulating rats than in CI animals (51.39 { 2.41 vs. 64.22 { 4.38; the generation of free radicals by the damaged liver and/ P õ 0.01) and significanly higher in these two groups or by stimulating cell defenses against oxidative stress. of rats than in healthy controls (32.67 { 1.28; P õ Table 2 shows activities of the antioxidant enzymes SOD, 0.001 for both). As seen in Figure 3 , there was a close GHSPx, and catalase in the liver in healthy control rats, direct correlation between the histological score of fibrocirrhotic rats, and cirrhotic rats treated with IGF-I. As sis and liver collagen content (r Å 0.758; P õ 0.001).
can be seen, these values were significantly higher in CI The histological score of fibrosis was also lower in CI / / IGF rats than in CI animals in the two protocols, with IGF than in CI rats from protocol 2 (CI / IGF, 11.6 { the sole exception of catalase in protocol 2. Interestingly, 0.4; CI, 13.2 { 0.3; P õ 0.05).
a close inverse correlation was found between MDA levels Lipid Peroxidation and Activities of (reflecting oxidative damage) and GSHPx activity (proAntioxidant Enzymes tection against oxidative stress) both in protocol 1 (r Å 00.91; P õ 0.001) and in protocol 2 (r Å 00.89; P õ In the two experimental protocols, the hepatic 0.001) ( Figures 5A and B) . IGF-I treatment showed no levels of the lipid peroxidation products (estimated as effect on the activity of antioxidant enzymes in normal nanomoles of MDA per gram of tissue) were increased livers (data not shown). in CI rats compared with healthy controls (protocol 1: CI, 138 { 25; CO, 39.0 { 2.4; P õ 0.05; protocol 2:
MTP and Protein Content of the CI, 133.0 { 26.9, CO, 61.8 { 1.6; P õ 0.05). This
Mitochondrial Fraction finding is in accordance with the known toxic effect of Because it has been shown that injured mitochonCCl 4 that causes oxidative damage in the liver. At first dria may generate free radicals and thus perpetuate cell glance it seems paradoxical that liver MDA levels per damage in the diseased liver, 10,12,20,32,33 we investigated gram of tissue are similar in CI rats from protocols 1 whether IGF-I treatment of cirrhotic rats could influence and 2 because there was a longer exposure to the toxic mitochondrial function. Thus, we analyzed protein conin the last protocol. However, it must be considered that tent of the mitochondrial fraction and MTP, a sensitive because the severity of liver fibrosis is higher in rats from marker of mitochondrial integrity, in rats from protocol protocol 2, the amount of parenchyma per gram of liver 2. tissue should be expected to be reduced in these animals.
As shown in Table 3 , total protein content of the Interestingly, we found that MDA values in CI / IGF mitochondrial fraction was significantly reduced in unanimals from the two protocols were not significantly treated cirrhotic rats compared with controls, whereas CI different from those observed in normal rats (CI / IGF-/ IGF-I animals had significantly higher values than I: protocol 1, 70 { 9.4; protocol 2, 92.2 { 6.6). In untreated cirrhotic rats and values similar to those of protocol 1, MDA values in CI / IGF rats were signifihealthy rats. Similarly, MTP, as estimated by the intencantly reduced compared with those obtained in CI anisity of fluorescence after 30-minute incubation with rhomals (P õ 0.05) ( Figure 4A ). In protocol 2, CI / IGF damine 123 suspension (IFLg ; Table 3 ), was significantly rats also tended to have less lipid peroxidation than CI decreased in CI rats but was within normal values in CI animals, but differences did not reach statistical signifi-/ IGF animals. In addition, the uptake of rhodamine cance ( Figure 4B) .
123 was significantly faster in the CI / IGF group than On the basis of these results it seems that IGF-I adin CI animals (Table 3) . These findings indicate disturbed ministration reduces lipid peroxidation in rats with exmitochondrial function in rats with CCl 4 -induced cirrhoperimental cirrhosis. In additional experiments, we also sis and improved mitochondrial integrity in the group analyzed whether IGF-I might also reduce liver MDA of cirrhotic rats treated with IGF-I. levels in healthy normal rats. Ten normal rats from protoDiscussion col 1 were treated with IGF-I for 2 weeks, and MDA levels were measured in liver tissue. We observed a sigThis study analyzed the effect of IGF-I on liver damage and function in rats with CCl 4 -induced cirrhosis. nificant reduction in liver MDA values in this group of Oxidative insult causes lipid peroxidation of cell and organelle membranes, oxidation of critical thiol groups, and disruption of cytoskeletal integrity leading to cell necrosis.
9,10 Mitochondria are recognized as the main sites at which peroxidation of membrane lipids takes place. 32, 33 Damaged mitochondria, in turn, generate toxic amounts of reactive oxygen species, 20, 32 thus contributing to cell damage even after cessation of the initial toxic insult.
9,23
Our results suggest that the observed cytoprotective effect of IGF-I in animals with CCl 4 -induced liver injury may be partly caused by decreased peroxidative cell damage. In the two protocols, the levels of lipid peroxidation products in livers from CI rats were significantly higher than in normal controls but they were not different from substance had been stopped days before the initiation of IGF-I administration, than in protocol 2, in which CCl 4 was not withdrawn. Two different protocols were used: rats from protocol 1
In an attempt to characterize the protection afforded showed compensated cirrhosis and were treated with IGF-I for 2 weeks starting 10 days after interruption of CCl 4 , and rats from protocol 2 showed advanced cirrhosis and IGF-I was given during the last 3 weeks of the study without interrupting CCl 4 administration. In the two protocols, IGF-I at low doses (2 mg/100 g body wt daily) was found to improve liver biosynthetic functions, to exert protection against oxidative liver damage, and to reduce hepatic fibrosis.
In the two protocols, untreated cirrhotic rats showed a significant reduction of serum albumin, total protein, and blood glucose levels, whereas in CI / IGF animals these parameters did not differ from healthy controls. Moreover, in compensated cirrhotic rats, IGF-I treatment significantly increased clotting factor activity and normalized prothrombin time. These results are in accordance with the wide range of anabolic activities described for IGF-I, 8 but the reduction in liver fibrosis observed in cirrhotic rats treated with IGF-I observed in the two protocols was an unexpected finding.
The in vivo antifibrogenic effect of IGF-I in CCl 4 -induced cirrhosis is in apparent contrast with the reported role for IGF-I as stimulator of Ito cell proliferation in vitro [34] [35] [36] [37] and with the observation of increased expression of IGF receptors during the process of fibrogenesis.
38
The combined effects of improving liver function and reducing collagen deposition prompted us to analyze the influence of IGF-I therapy on peroxidative liver damage, because this process is the essential mechanism of cell collagen gene expression.
16 by IGF-I against free radical damage, we investigated cytoprotective activity of IGF-I against pro-oxidant injury could be through the stimulation of reduced synthethe effect of IGF-I on antioxidant enzymes and on mitochondrial function, because the former are relevant comsis, as has been described for S-adenosylmethionine treatment. 39 However, this last mechanism was not explored ponents of the cell defense against pro-oxidant injury and damaged mitochondria are an important source of in the present study. In our study, the activities of the antioxidant enzymes free radicals. An additional mechanism to explain the SOD, GSHPx, and catalase were reduced in untreated cirrhotic rats but returned to normal (with the exception of catalase in protocol 2) in cirrhotic rats receiving IGF-I. The effect of IGF-I enhancing GSHPx activity in cirrhotic livers may have special pathophysiological importance because this enzyme is considered to be the main enzymatic defense against the oxidative destruction of biomembranes in mitochondria and other organelles; it is also known to participate in the metabolism of lipid hydroperoxides. 21, 40 In fact, we have observed a close inverse correlation between hepatic levels of lipid peroxidation products and the activity of GSHPx in liver tissue. It is possible that these changes in SOD, GSHPx, and catalase activities do not reflect a specific effect of IGF-I on antioxidant enzymatic systems but rather the general anabolic properties of the hormone, promoting protein synthesis in damaged liver cells.
As mentioned, injured mitochondria can be an im- portant source of free radicals and thus contributes to I in situations in which hepatocellular damage and fibrogenesis occur as a consequence of pro-oxidant injury persisting cell damage. 23, 32, 33 In this study, IGF-I treatment was associated with a recovery of MTP and mitoto the liver. chondrial protein content to normal. It seems that
